World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
91
Citations
24869
World Ranking
11920
National Ranking
6114

Axel R. Zander publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Axel R. Zander sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 523 publications — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Axel R. Zander D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Axel R. Zander sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 91 D-Index — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Axel R. Zander is affiliated with the Huntsman Cancer Institute in the United States. Their research focuses primarily on the field of Medicine, with significant contributions to several subfields including Hematology, Immunology, Genetics, Public Health, Environmental and Occupational Health, and Oncology.

Their scholarly work addresses a range of topics broadly centered around hematological malignancies and immune system functioning. Main topics in their research include:

  • Hematopoietic Stem Cell Transplantation
  • Immune Cell Function and Interaction
  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Acute Lymphoblastic Leukemia research
  • Chronic Lymphocytic Leukemia Research
  • Thermodynamics and calorimetric analyses

Axel R. Zander has contributed multiple papers to prominent scientific journals, with recent publications including:

  • Impact of Anti-T-lymphocyte globulin dosing on GVHD and Immune reconstitution in matched unrelated myeloablative peripheral blood stem cell transplantation, 2022, Bone Marrow Transplantation
  • Profile of Checkpoint Molecules Expression on Bone Marrow Cell Populations in Patients with High-Risk Myelodysplastic Syndrome, 2020, Blood
  • Predictive Model of Response to Blinatumomab Therapy in Children and Adults with Relapsed/Refractory B-ALL, 2020, Blood
  • Rolf Neth (October 6, 1926 to March 17, 2020), 2020, Leukemia
  • Factors Affecting Post-Transplant Relapse of Acute Lymphoblastic Leukemia (ALL) in Children According on the Intensity of Conditioning, 2020, Blood

Their work has been published frequently in the journal Blood, which accounts for six of their publications, alongside other contributions to Cancer Research, Leukemia, Cellular Therapy and Transplantation, and Bone Marrow Transplantation.

Axel R. Zander collaborates frequently with several researchers in their field. The most common coauthors include:

  • Ivan Moiseev
  • Sergey N. Bondarenko
  • L. S. Zubarovskaya
  • Elena V. Babenko
  • Inna V. Markova

Best Publications

  • Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia.

    Vanderson Rocha;Jacqueline Cornish;Eric L. Sievers;Alexandra Filipovich

  • Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

    Jürgen Finke;Wolfgang A Bethge;Claudia Schmoor;Hellmut D Ottinger

  • Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

    N Schmitz;P Dreger;D.C Linch;A.H Goldstone

  • Administered mesenchymal stem cells enhance recovery from ischemia/reperfusion-induced acute renal failure in rats.

    Claudia Lange;Florian Tögel;Harald Ittrich;Frederic Clayton

  • Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Nicolaus Kröger;Ernst Holler;Guido Kobbe;Martin Bornhäuser

  • Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use.

    Norbert Stute;Katja Holtz;Michael Bubenheim;Claudia Lange

  • Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.

    Gérard Socié;Claudia Schmoor;Wolfgang A. Bethge;Hellmut D. Ottinger

  • Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation

    N. Schmitz;A. Bacigalupo;D. Hasenclever;Arnon Nagler

  • Evidence of a Graft-Versus-Leukemia Effect in Chronic Lymphocytic Leukemia After Reduced-Intensity Conditioning and Allogeneic Stem-Cell Transplantation: The Cooperative German Transplant Study Group

    J. Schetelig;C. Thiede;M. Bornhäuser;R. Schwerdtfeger

  • Accelerated and safe expansion of human mesenchymal stromal cells in animal serum‐free medium for transplantation and regenerative medicine

    Claudia Lange;Figen Cakiroglu;Andrej-Nikolai Spiess;Heike Cappallo-Obermann

  • High-Dose Cyclophosphamide, Carmustine, and Etoposide and Autologous Bone Marrow Transplantation for Relapsed Hodgkin's Disease

    Sundar Jagannath;Karel A. Dicke;James O. Armitage;Fernando F. Cabanillas

  • Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era : evaluation of its impact within a subgroup of the randomized German CML Study IV

    Susanne Saussele;Michael Lauseker;Alois Gratwohl;Dietrich W. Beelen

  • Outcome of Allogeneic Hematopoietic Stem-Cell Transplantation in Adult Patients With Acute Lymphoblastic Leukemia: No Difference in Related Compared With Unrelated Transplant in First Complete Remission

    Michael G. Kiehl;Ludwig Kraut;Rainer Schwerdtfeger;Bernd Hertenstein

  • Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT.

    Charles Crawley;Marc Lalancette;Richard Szydlo;Maria H Gilleece

  • Unrelated stem cell transplantation in multiple myeloma after a reduced-intensity conditioning with pretransplantation antithymocyte globulin is highly effective with low transplantation-related mortality

    Nicolaus Kröger;Herbert Gottfried Sayer;Rainer Schwerdtfeger;Michael Kiehl

  • Liver-specific gene expression in cultured human hematopoietic stem cells.

    Henning C. Fiegel;Michael V. Lioznov;Lourdes Cortes-Dericks;Claudia Lange

  • Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT.

    Charles Crawley;Richard Szydlo;Marc Lalancette;Andrea Bacigalupo

  • Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

    André Tichelli;Jakob Passweg;Dorota Wójcik;Alicia Rovó

  • Detection of Virulence-Associated Genes Not Useful for Discriminating between Invasive and Commensal Staphylococcus epidermidis Strains from a Bone Marrow Transplant Unit

    Holger Rohde;Matthias Kalitzky;Nicolaus Kröger;Stefanie Scherpe

  • Treosulfan/fludarabine: a new conditioning regimen in allogeneic transplantation.

    J Casper;W Knauf;I Blau;T Ruutu

Frequent Co-Authors

Nicolaus Kröger
Nicolaus Kröger Universität Hamburg
Boris Fehse
Boris Fehse Universität Hamburg
Arnon Nagler
Arnon Nagler Sheba Medical Center
Dietger Niederwieser
Dietger Niederwieser Leipzig University
Ernst Holler
Ernst Holler University of Regensburg
Hans-Jochem Kolb
Hans-Jochem Kolb Ludwig-Maximilians-Universität München
Jürgen Finke
Jürgen Finke University of Freiburg
Carsten Bokemeyer
Carsten Bokemeyer Universität Hamburg
Gérard Socié
Gérard Socié Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Choosing to study Medicine in the USA opens the door to a wide array of related healthcare degrees and alternative career pathways. For those interested in entering the workforce quickly, accelerated lpn program options provide a fast track to becoming a Licensed Practical Nurse, sometimes in as little as 12 months.

If your focus is on advanced nursing or mental health, you might consider exploring the shortest online pmhnp programs. These programs prepare you for specialized roles in psychiatric and mental health nursing with flexible online study options.

For those driven by leadership or administration, graduate degrees in healthcare administration offer promising routes. Multiple programs exist to help you find the cheapest mha programs online, allowing you to earn a respected degree without an enormous financial burden.

Additionally, students can compare options for the cheapest online mha programs to further maximize affordability and flexibility. These programs are excellent choices for aspiring healthcare managers seeking accessible and budget-friendly education for career advancement.

Best Scientists Citing Axel R. Zander

Trending Scientists

Recently Published Articles